Abstract:Acute Respiratory Distress Syndrome (ARDS) is an important global health issue with high in-hospital mortality. Importantly, the impact of ARDS extends beyond the acute phase, with increased mortality and disability for months to years after hospitalization. These findings underscore the importance of extended follow-up to assess and address the Post-Intensive Care Syndrome (PICS), characterized by persistent impairments in physical, cognitive, and/or mental health status that impair quality of life over the long-term. Persistent muscle weakness is a common physical problem for ARDS survivors, affecting mobility and activities of daily living. Critical illness and related interventions, including prolonged bed rest and overuse of sedatives and neuromuscular blocking agents during mechanical ventilation, are important risk factors for ICU-acquired weakness. Deep sedation also increases the risk of delirium in the ICU, and long-term cognitive impairment. Corticosteroids also may be used during management of ARDS, particularly in the setting of COVID-19. Corticosteroids can be associated with myopathy and muscle weakness, as well as prolonged delirium that increases the risk of long-term cognitive impairment. The optimal duration and dosage of corticosteroids remain uncertain, and there's limited long-term data on their effects on muscle weakness and cognition in ARDS survivors. In addition to physical and cognitive issues, mental health challenges, such as depression, anxiety, and post-traumatic stress disorder, are common in ARDS survivors. Strategies to address these complications emphasize the need for consistent implementation of the evidence-based ABCDEF bundle, which includes daily management of analgesia in concert with early cessation of sedatives, avoidance of benzodiazepines, daily delirium monitoring and management, early mobilization, and incorporation of family at the bedside. In conclusion, ARDS is a complex global health challenge with consequences extending beyond the acute phase. Understanding the links between critical care management and long-term consequences is vital for developing effective therapeutic strategies and improving the quality of life for ARDS survivors.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the relationship between the acute - phase management and long - term rehabilitation of patients with Acute Respiratory Distress Syndrome (ARDS), and how to improve the long - term prognosis of ARDS patients. Specifically, the paper focuses on the following aspects: 1. **Long - term effects of ARDS**: - ARDS not only has a high mortality rate (about 40%) during hospitalization, but its effects also extend to months or even years after discharge, resulting in higher long - term mortality and disability rates. - Many ARDS survivors still have physical, cognitive and mental health problems after discharge, which are collectively known as Post - Intensive Care Syndrome (PICS). 2. **ICU - acquired weakness (CIW)**: - Persistent muscle weakness is one of the most common long - term physical obstacles for ARDS survivors, affecting their mobility and activities of daily living. - Inactivity during intensive care, long - term bed rest, and excessive use of sedatives and neuromuscular blockers (NMBA) and other treatment measures are important risk factors for ICU - acquired weakness. 3. **Effects of drug use**: - Glucocorticoids (such as dexamethasone) are widely used in ARDS management, especially in COVID - 19 - related ARDS, but these drugs may increase the risk of myopathy and muscle weakness, and may cause delirium, thereby increasing the risk of long - term cognitive impairment. - The use of opioid drugs and other sedatives is also related to the occurrence of delirium, thus affecting the long - term cognitive function of patients. 4. **Challenges in mental health**: - Mental health problems such as depression, anxiety and post - traumatic stress disorder (PTSD) are common problems among ARDS survivors, which seriously affect their quality of life. - Mental health problems not only affect the quality of life of patients, but may also increase the risk of suicide and self - harm. 5. **Comprehensive management strategies**: - The paper emphasizes the importance of the ABCDEF bundle (including daily assessment and adjustment of analgesia, early cessation of sedatives, avoidance of benzodiazepines, daily monitoring and management of delirium, early mobilization and family participation) to reduce the occurrence of PICS and improve the long - term prognosis of patients. In summary, this paper aims to propose effective treatment strategies to improve the long - term quality of life of ARDS patients by exploring the relationship between the acute - phase management and long - term rehabilitation of ARDS.

Improving management of ARDS: uniting acute management and long-term recovery

Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness

Management of the acute respiratory distress syndrome

Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms

Management of ARDS - What Works and What Does Not

Challenges in Transitioning from Controlled to Assisted Ventilation in Acute Respiratory Distress Syndrome (ARDS) Management

Long-term outcomes in critically ill patients with acute respiratory failure

Management of severe acute respiratory distress syndrome: a primer

What's Next After ARDS: Long-Term Outcomes

Challenges in ARDS Definition, Management, and Identification of Effective Personalized Therapies

Tackling Brain and Muscle Dysfunction in Acute Respiratory Distress Syndrome Survivors: National Heart, Lung, and Blood Institute Workshop Report

Innovations in protective mechanical ventilation for acute respiratory distress syndrome management

Aviptadil: A multifaceted approach to mitigating hypoxemia in acute respiratory distress syndrome

The Effectiveness of Corticosteroids on Mortality in Patients with Acute Respiratory Distress Syndrome or Acute Lung Injury: a Secondary Analysis

Sequelae of Acute Respiratory Distress Syndrome: Interest of Rehabilitation

Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS

Recent advances in the understanding and management of ARDS

Personalized Respiratory Support in ARDS: A Physiology-to-Bedside Review

Lessons to learn from epidemiologic studies in ARDS

Impact of cardiovascular risk factors and cardiac diseases on mortality in patients with moderate to severe ARDS: A retrospective cohort study

Analgesia and sedation in patients with ARDS